ORIC Pharmaceuticals Inc 4TZ
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €11.61
- Day Range
- €11.14–11.22
- 52-Week Range
- —–—
- Bid/Ask
- €0.00 / €0.00
- Shares Outstanding
- 103.65M
- Market Cap
- $1.16B
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 111
- Website
- https://www.oricpharma.com
Valuation
|
Metric
|
4TZ
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 3.60 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
4TZ
|
|---|---|
Quick Ratio | 12.76 |
Current Ratio | 13.19 |
Interest Coverage | — |
Quick Ratio
4TZ
Profitability
|
Metric
|
4TZ
|
|---|---|
Return on Assets (Normalized) | −28.21% |
Return on Equity (Normalized) | −29.93% |
Return on Invested Capital (Normalized) | −29.67% |
Return on Assets
4TZ
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|!%b#?# | LOCK|J!G?M | $128B | |||
| Moderna Inc
MRNA
| LOCK|Z^&$F^# | LOCK|?! | $76B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|Dh@y>wM | LOCK|lw%@ | $76B | |||
| argenx SE ADR
ARGX
| LOCK|^?x%m> | LOCK|sX! | $57B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|XxrbZwd | LOCK|CTm | $41B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|ct%^yC | LOCK|mB@nW | $29B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|WQkbS#& | LOCK|BYTX | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|$W$Tf$? | LOCK|?>x | $24B | |||
| Incyte Corp
INCY
| LOCK|qxGy&Zy | LOCK|F^g | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|Xr?B^B@ | LOCK|>$H | $15B |
United States